O’neil W. Guthrie is the director of the cell and molecular pathology laboratory in wettaw biochemistry at Northern Arizona University. In addition to his research credentials, he is also a licensed clinical audiologist with decades of diagnostic and rehabilitation experiences. His basic science research program is focused on revealing molecular mechanisms that regulate the integrity of active genes and the engineering of biomedical approaches to enhance the capacity of cells to protect their DNA. To this end, Dr. Guthrie’s research group employs a range of genetic, epigenetic, molecular and pharmacologic strategies to regulate cellular DNA repair capacity. The research from this work has led to patented and unpatented molecular constructs that could affect clinical outcomes. In addition to his basic science research program, Dr. Guthrie is also interested in translational research that improves clinical and epidemiology outcomes. His research on the interaction between jet-propulsion fuel and background noise exposure has revealed that such combined exposures can disrupt brain functions without peripheral nervous system impairment or hearing loss. Dr. Guthrie received his B.S. and M.S. degrees from the State University of New York campuses at Geneseo and Fredonia. He completed research training in molecular biology and audiology at the University of Pittsburgh where he earned a Ph.D. He then completed postdoctoral training in molecular genetics at Duke University where he w
O’neil W. Guthrie is the director of the cell and molecular pathology laboratory in wettaw biochemistry at Northern Arizona University. In addition to his research credentials, he is also a licensed clinical audiologist with decades of diagnostic and rehabilitation experiences. His basic science research program is focused on revealing molecular mechanisms that regulate the integrity of active genes and the engineering of biomedical approaches to enhance the capacity of cells to protect their DNA. To this end, Dr. Guthrie’s research group employs a range of genetic, epigenetic, molecular and pharmacologic strategies to regulate cellular DNA repair capacity. The research from this work has led to patented and unpatented molecular constructs that could affect clinical outcomes. In addition to his basic science research program, Dr. Guthrie is also interested in translational research that improves clinical and epidemiology outcomes. His research on the interaction between jet-propulsion fuel and background noise exposure has revealed that such combined exposures can disrupt brain functions without peripheral nervous system impairment or hearing loss. Dr. Guthrie received his B.S. and M.S. degrees from the State University of New York campuses at Geneseo and Fredonia. He completed research training in molecular biology and audiology at the University of Pittsburgh where he earned a Ph.D. He then completed postdoctoral training in molecular genetics at Duke University where he w